Cargando…

Clinical diagnostic biomarker “circulating tumor cells” in breast cancer - a meta-analysis

OBJECTIVE: Using meta-analysis, we evaluate circulating tumor cells(CTCs) as a potential diagnostic tool for breast cancer. METHODS: A document search was conducted using publicly available databases up to May 2021. Specific inclusion and exclusion criteria were formulated and summarize relevant dat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bai, Shiyan, Lin, Shujin, Lin, Ting, Wang, Qiaowen, Cheng, Cui, Lin, Junru, Zhang, Ying, Jiang, Xiwen, Han, Xiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313226/ https://www.ncbi.nlm.nih.gov/pubmed/37397397 http://dx.doi.org/10.3389/fonc.2023.1137519

Ejemplares similares

Circulating tumor cells in peripheral blood as a diagnostic biomarker of breast cancer: A meta-analysis
por: Jin, Tao, et al.
Publicado: (2023)

The Application of Prussian Blue Nanoparticles in Tumor Diagnosis and Treatment
por: Gao, Xiaoran, et al.
Publicado: (2020)

Meta-Analysis of Peripheral Blood Transcriptome Datasets Reveals a Biomarker Panel for Tuberculosis in Patients Infected With HIV
por: Chen, Yahong, et al.
Publicado: (2021)

Evaluation of Cell Surface Vimentin Positive Circulating Tumor Cells as a Diagnostic Biomarker for Lung Cancer
por: Xie, Xiaohong, et al.
Publicado: (2021)

Diagnostic Value of Concentration of Circulating Cell-Free DNA in Breast Cancer: A Meta-Analysis
por: Yu, Dandan, et al.
Publicado: (2019)

Research Progress on Synthesis and Application of Cyclodextrin Polymers
por: Liu, Yuan, et al.
Publicado: (2021)

Circulating tumor biomarkers in early-stage breast cancer: characteristics, detection, and clinical developments
por: Qiu, Jie, et al.
Publicado: (2023)

Circulating Long Noncoding RNAs Act as Diagnostic Biomarkers in Non-Small Cell Lung Cancer
por: Yuan, Shuai, et al.
Publicado: (2020)

Cell-free circulating tumor RNAs in plasma as the potential prognostic biomarkers in colorectal cancer
por: Jin, Nana, et al.
Publicado: (2023)

Circulating miRNAs as Auxiliary Diagnostic Biomarkers for Multiple Myeloma: A Systematic Review, Meta-Analysis, and Recommendations
por: Xiang, Yunhui, et al.
Publicado: (2021)

Detection Methods and Clinical Applications of Circulating Tumor Cells in Breast Cancer
por: Zhang, Hongyi, et al.
Publicado: (2021)

A comprehensive comparison of circulating tumor cells and breast imaging modalities as screening tools for breast cancer in Chinese women
por: Shao, Xuan, et al.
Publicado: (2022)

Circulating miRNAs as Diagnostic and Prognostic Biomarkers in High-Grade Gliomas
por: Wu, Jianing, et al.
Publicado: (2022)

Prognostic and predictive significance of circulating biomarkers in patients with advanced upper gastrointestinal cancer undergoing systemic chemotherapy
por: Li, Ningning, et al.
Publicado: (2023)

Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients
por: Chan, Hiu Ting, et al.
Publicado: (2023)

Diagnostic value of mammography density of breast masses by using deep learning
por: Chen, Qian-qian, et al.
Publicado: (2023)

Diagnostic value of circulating lncRNAs for gastric cancer: A systematic review and meta-analysis
por: Li, Jian, et al.
Publicado: (2022)

The Diagnostic Performance of Diffusion Kurtosis Imaging in the Characterization of Breast Tumors: A Meta-Analysis
por: Li, Zhipeng, et al.
Publicado: (2020)

Diagnostic significance and utility of circulating redox biomarkers in patients with gastric cancer – preliminary study
por: Dorf, Justyna, et al.
Publicado: (2023)

Prognostic Relevance of Estrogen Receptor Status in Circulating Tumor Cells in Breast Cancer Patients Treated With Endocrine Therapy
por: Zhou, Ying, et al.
Publicado: (2022)

The Prognostic Value of Circulating Soluble Programmed Death Ligand-1 in Cancers: A Meta-Analysis
por: Huang, Pei, et al.
Publicado: (2021)

Circulating Tumor Cells: A Promising Biomarker in the Management of Nasopharyngeal Carcinoma
por: Wu, Jiangtao, et al.
Publicado: (2021)

Prognostic value of epithelial–mesenchymal transition circulating tumor cells in female breast cancer: A meta-analysis
por: Zhao, Qiang, et al.
Publicado: (2022)

Circulating Tumor Cell Identification Based on Deep Learning
por: Guo, Zhifeng, et al.
Publicado: (2022)

SENP3 promotes tumor progression and is a novel prognostic biomarker in triple-negative breast cancer
por: Zhu, Youzhi, et al.
Publicado: (2023)

Diagnostic Performance of Diffusion Tensor Imaging for Characterizing Breast Tumors: A Comprehensive Meta-Analysis
por: Wang, Kai, et al.
Publicado: (2019)

Potential Applications of Circulating Tumor DNA Technology as a Cancer Diagnostic Tool
por: Kunnath, Anil P, et al.
Publicado: (2019)

GLS as a diagnostic biomarker in breast cancer: in-silico, in-situ, and in-vitro insights
por: Zhang, Danfeng, et al.
Publicado: (2023)

Vitamin D and circulating tumor cells in primary breast cancer
por: Mego, Michal, et al.
Publicado: (2022)

Tumor-derived extracellular vesicle nucleic acids as promising diagnostic biomarkers for prostate cancer
por: Diao, Yanjun, et al.
Publicado: (2023)

Evaluation of circulating tumor DNA as a prognostic biomarker for metastatic pancreatic adenocarcinoma
por: Guan, Shasha, et al.
Publicado: (2022)

Circulating Tumor Biomarkers in Meningiomas Reveal a Signature of Equilibrium Between Tumor Growth and Immune Modulation
por: Erkan, Erdogan Pekcan, et al.
Publicado: (2019)

Machine learning-featured Secretogranin V is a circulating diagnostic biomarker for pancreatic adenocarcinomas associated with adipopenia
por: Jo, Yunju, et al.
Publicado: (2022)

AI diagnostic performance based on multiple imaging modalities for ovarian tumor: A systematic review and meta-analysis
por: Ma, Lin, et al.
Publicado: (2023)

Editorial: Diagnostic and predictive biomarkers in testicular germ cell tumors
por: Lobo, João, et al.
Publicado: (2022)

The Diagnostic Performance of Minimally Invasive Biopsy in Predicting Breast Pathological Complete Response After Neoadjuvant Systemic Therapy in Breast Cancer: A Meta-Analysis
por: Li, Yan, et al.
Publicado: (2020)

Circulating tumour DNA as biomarker for rectal cancer: A systematic review and meta-analyses
por: van Rees, Jan M., et al.
Publicado: (2023)

Circulating Serum Exosomal Long Non-Coding RNAs FOXD2-AS1, NRIR, and XLOC_009459 as Diagnostic Biomarkers for Colorectal Cancer
por: Yu, Miao, et al.
Publicado: (2021)

Effect of activating cancer-associated fibroblasts biomarker TNC on immune cell infiltration and prognosis in breast cancer
por: Huang, Ting, et al.
Publicado: (2023)

Circulating Tumor Cell and Metabolites as Novel Biomarkers for Early-Stage Lung Cancer Diagnosis
por: Wan, Lingling, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ongut8bhdgg77fs7r8hb8lc00q